Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × palbociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasm Metastasis 11 Neoplasms 8 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Breast Diseases 4 Sarcoma 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Liposarcoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumors 2 Advanced Breast Cancer 2 von Hippel-Lindau Disease 1 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Venous Thromboembolism 1

Interventions

Azacitidine 29 venetoclax 21 Cyclophosphamide 17 Whole-Body Irradiation 14 fludarabine phosphate 13 Biopsy 13 fludarabine 12 Tacrolimus 12 Specimen Handling 12 Mycophenolic Acid 11 Decitabine 11 Cytarabine 10 Stem Cell Transplantation 9 Peripheral Blood Stem Cell Transplantation 9 Injections 8 decitabine and cedazuridine drug combination 7 Melphalan 7 Busulfan 6 X-Rays 5 Hematopoietic Stem Cell Transplantation 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Cyclosporine 4 sabatolimab 3 olutasidenib 3 enasidenib 3 cedazuridine 3 Sirolimus 3 Rituximab 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡